An unprecedented bowel cancer study resulted in all patients being rid of the disease thanks to an experimental drug.
The US study used a womb cancer drug known as dostarlimab in a trial with colorectal cancer patients.
Though the study was small, its results saw cancer vanishing in all 18 patients and tears of joy.